123 related articles for article (PubMed ID: 30213788)
1. Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma.
Spel L; Nieuwenhuis J; Haarsma R; Stickel E; Bleijerveld OB; Altelaar M; Boelens JJ; Brummelkamp TR; Nierkens S; Boes M
Cancer Res; 2018 Dec; 78(23):6621-6631. PubMed ID: 30213788
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells.
Forloni M; Albini S; Limongi MZ; Cifaldi L; Boldrini R; Nicotra MR; Giannini G; Natali PG; Giacomini P; Fruci D
Cancer Res; 2010 Feb; 70(3):916-24. PubMed ID: 20103633
[TBL] [Abstract][Full Text] [Related]
3. NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes.
Molinero LL; Fuertes MB; Girart MV; Fainboim L; Rabinovich GA; Costas MA; Zwirner NW
J Immunol; 2004 Nov; 173(9):5583-90. PubMed ID: 15494508
[TBL] [Abstract][Full Text] [Related]
4. NFκB and MHC-1 Interplay in Neuroblastoma and Immunotherapy.
Spel L; Schiepers A; Boes M
Trends Cancer; 2018 Nov; 4(11):715-717. PubMed ID: 30352674
[TBL] [Abstract][Full Text] [Related]
5. Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.
Blanchet O; Bourge JF; Zinszner H; Israel A; Kourilsky P; Dausset J; Degos L; Paul P
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3488-92. PubMed ID: 1565643
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocompatibility class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cells.
Drew PD; Franzoso G; Carlson LM; Biddison WE; Siebenlist U; Ozato K
J Neuroimmunol; 1995 Dec; 63(2):157-62. PubMed ID: 8550813
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1.
Khanolkar RC; Kalogeropoulos M; Lawrie A; Roghanian A; Vickers MA; Young NT
J Leukoc Biol; 2016 Oct; 100(4):737-746. PubMed ID: 27129285
[TBL] [Abstract][Full Text] [Related]
9. In adenovirus type 12 tumorigenic cells, major histocompatibility complex class I transcription shutoff is overcome by induction of NF-kappaB and relief of COUP-TFII repression.
Hou S; Guan H; Ricciardi RP
J Virol; 2002 Apr; 76(7):3212-20. PubMed ID: 11884545
[TBL] [Abstract][Full Text] [Related]
10. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
[TBL] [Abstract][Full Text] [Related]
11. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
[TBL] [Abstract][Full Text] [Related]
12. NF-κB regulates caspase-4 expression and sensitizes neuroblastoma cells to Fas-induced apoptosis.
Yang HJ; Wang M; Wang L; Cheng BF; Lin XY; Feng ZW
PLoS One; 2015; 10(2):e0117953. PubMed ID: 25695505
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells.
Karacay B; Sanlioglu S; Griffith TS; Sandler A; Bonthius DJ
Cancer Gene Ther; 2004 Oct; 11(10):681-90. PubMed ID: 15332116
[TBL] [Abstract][Full Text] [Related]
14. All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
Farina AR; Masciulli MP; Tacconelli A; Cappabianca L; De Santis G; Gulino A; Mackay AR
Cell Growth Differ; 2002 Aug; 13(8):343-54. PubMed ID: 12193473
[TBL] [Abstract][Full Text] [Related]
15. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway.
Al-Sadi R; Guo S; Ye D; Rawat M; Ma TY
Am J Pathol; 2016 May; 186(5):1151-65. PubMed ID: 26948423
[TBL] [Abstract][Full Text] [Related]
16. Role of IkappaBalpha and IkappaBbeta in the biphasic nuclear translocation of NF-kappaB in TNFalpha-stimulated astrocytes and in neuroblastoma cells.
Kemler I; Fontana A
Glia; 1999 May; 26(3):212-20. PubMed ID: 10340762
[TBL] [Abstract][Full Text] [Related]
17. N-myc suppresses major histocompatibility complex class I gene expression through down-regulation of the p50 subunit of NF-kappa B.
van 't Veer LJ; Beijersbergen RL; Bernards R
EMBO J; 1993 Jan; 12(1):195-200. PubMed ID: 8428579
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.
Choudhary S; Boldogh S; Garofalo R; Jamaluddin M; Brasier AR
J Virol; 2005 Jul; 79(14):8948-59. PubMed ID: 15994789
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in neuroblastoma cells through a nuclear factor-kappaB and activating protein-1 mediated mechanism.
Alvarez S; Serramía MJ; Fresno M; Muñoz-Fernández M
J Neurochem; 2005 Aug; 94(3):850-61. PubMed ID: 16001969
[TBL] [Abstract][Full Text] [Related]
20. NIK controls classical and alternative NF-κB activation and is necessary for the survival of human T-cell lymphoma cells.
Odqvist L; Sánchez-Beato M; Montes-Moreno S; Martín-Sánchez E; Pajares R; Sánchez-Verde L; Ortiz-Romero PL; Rodriguez J; Rodríguez-Pinilla SM; Iniesta-Martínez F; Solera-Arroyo JC; Ramos-Asensio R; Flores T; Palanca JM; Bragado FG; Franjo PD; Piris MA
Clin Cancer Res; 2013 May; 19(9):2319-30. PubMed ID: 23536439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
